Centessa Pharma 命名新的首席执行官,以将奥克辛疗法扩大到新的神经科学疗法。 Centessa Pharma names new CEO to expand orexin therapies into new neuroscience treatments.

Centessa制药公司已宣布向首席执行官过渡,因为该公司正在推进其战略,将基于蛋白质的治疗扩大至超出现有迹象的多种神经科学领域,表明在神经和精神紊乱的治疗正在发展之中,领导层正在发生转变。 Centessa Pharmaceuticals has announced a CEO transition as it advances its strategy to expand its orexin-based therapies beyond existing indications into multiple neuroscience areas, signaling a shift in leadership amid ongoing development of treatments for neurological and psychiatric disorders.